Matches in Wikidata for { <http://www.wikidata.org/entity/Q66078525> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q66078525 description "clinical trial" @default.
- Q66078525 description "ensayu clínicu" @default.
- Q66078525 description "klinisch onderzoek" @default.
- Q66078525 description "клінічне випробування" @default.
- Q66078525 name "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 name "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 type Item @default.
- Q66078525 label "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 label "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 prefLabel "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 prefLabel "A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia" @default.
- Q66078525 P1050 Q66078525-AD3A05D0-0CA3-4EC3-A8D0-8AA4595AFDAC @default.
- Q66078525 P1132 Q66078525-5A316A8C-CB33-4124-8887-8DB9FDA319B7 @default.
- Q66078525 P1476 Q66078525-6570DDED-AE95-433B-99AF-5DD2B66F921E @default.
- Q66078525 P17 Q66078525-2B9A6C7D-2EA2-4734-B11B-D9EDD9F42791 @default.
- Q66078525 P17 Q66078525-43D213A0-5025-4138-BA3A-F9034040C0DF @default.
- Q66078525 P17 Q66078525-A85179A5-9B60-4B3F-807C-FE308FACC45D @default.
- Q66078525 P17 Q66078525-C985B26F-4618-4767-9A7D-F3625E2EE15D @default.
- Q66078525 P2899 Q66078525-BB3685FF-695D-44BB-A73E-C9B242202715 @default.
- Q66078525 P3098 Q66078525-28A78E5A-0A90-45D3-AD42-BE81149DD194 @default.
- Q66078525 P31 Q66078525-3AFEDDE7-E3BA-4AD0-8519-6918051E96FF @default.
- Q66078525 P4135 Q66078525-F0294CE0-6772-4C3A-8377-942A4CDD7EDA @default.
- Q66078525 P580 Q66078525-BBBFDA1A-7957-4589-A8A5-B89D3840CFC1 @default.
- Q66078525 P582 Q66078525-A613FE2B-6710-42DA-8435-D26FC9D3FB2A @default.
- Q66078525 P6099 Q66078525-917C936D-D7AC-4CFC-8021-029A4755F40E @default.
- Q66078525 P6153 Q66078525-7AA539A7-9DC7-4C62-8A4E-0B330D905711 @default.
- Q66078525 P6153 Q66078525-B255175F-896B-4D10-94D1-40B1AA629AA5 @default.
- Q66078525 P8363 Q66078525-13338EEB-1286-438E-832C-A15D4E429B4E @default.
- Q66078525 P1050 Q41112 @default.
- Q66078525 P1132 "+245" @default.
- Q66078525 P1476 "A 4-Week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexibly-dosed, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adult Subjects With Schizophrenia" @default.
- Q66078525 P17 Q212 @default.
- Q66078525 P17 Q218 @default.
- Q66078525 P17 Q28 @default.
- Q66078525 P17 Q30 @default.
- Q66078525 P2899 "+18" @default.
- Q66078525 P3098 "NCT02969382" @default.
- Q66078525 P31 Q30612 @default.
- Q66078525 P4135 "+40" @default.
- Q66078525 P580 "2016-11-30T00:00:00Z" @default.
- Q66078525 P582 "2018-07-31T00:00:00Z" @default.
- Q66078525 P6099 Q42824440 @default.
- Q66078525 P6153 Q30269522 @default.
- Q66078525 P6153 Q30269674 @default.
- Q66078525 P8363 Q78089383 @default.